Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2026 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Present New Real-World Data at PainConnect 2026

STOUGHTON, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its portfolio of...
March 05, 2026 07:00 ET | Source: GH Research PLC

GH Research Reports Full Year 2025 Financial Results and Provides Business Update

Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP congressesGH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCash,...
March 03, 2026 09:12 ET | Source: Research and Markets

Botanical and Plant-derived Drugs Global Research Report 2025: A $58.1 Billion Market by 2030, Driven by Plant Metabolites for Drug Discovery and Biotechnological Integration for Personalized Medicine

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Botanical and Plant-derived Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for botanical and...
March 02, 2026 05:00 ET | Source: Spot.See

SpotSee and Controlant Announce Strategic Collaboration to Expand Shipment Visibility and Last-Mile Proof for Life Sciences

SpotSee and Controlant partner to expand life sciences temperature-sensitive supply chain visibility, cut returns and efficiently scale monitoring programs
February 27, 2026 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a...
February 26, 2026 07:30 ET | Source: Custom Market Insights

[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Laboratory Informatics Market Size, Trends and Insights By Product (Laboratory...
February 26, 2026 07:00 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Over 1.1 million total VOQUEZNA® prescriptions filled to date$57.6 million in Q4 net revenues; $175.1 million in FY 2025 net revenues, a 217% increase from FY 2024Q4 operating expenses of $55.9...
February 24, 2026 08:00 ET | Source: Lumanity

Lumanity Launches EMULaiTOR™, an AI-Powered Synthetic Persona Platform Transforming Stakeholder Engagement in Life Sciences

Lumanity announces the launch of EMULaiTOR™, a new AI-enabled platform designed to change how life sciences organizations prepare for engagement.
February 23, 2026 08:30 ET | Source: PharmAla Biotech

PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data

PharmAla to supply University of Amsterdam with LaNeo MDMA for a clinical trial, generating new stability data for blister packs in the process
February 23, 2026 08:00 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

FLORHAM PARK, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...